Stay updated with breaking news from Oblte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) rose 9.3% during mid-day trading on Thursday . The company traded as high as $20.70 and last traded at $20.35. Approximately 49,558 shares changed hands during trading, an increase of 72% from the average daily volume of 28,859 shares. The stock had previously closed at […]
Cantor Fitzgerald initiated coverage on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a report published on Friday morning, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $43.00 target price on the stock. BLTE has been the topic of several other reports. SVB Securities started coverage on shares of Belite Bio […]
Stock analysts at SVB Leerink started coverage on shares of Belite Bio (NASDAQ:BLTE – Get Free Report) in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage set an “outperform” rating and a $25.00 price target on the stock. SVB Leerink’s price target would indicate a potential upside of 34.26% […]
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Benchmark in a research report issued on Tuesday, Benzinga reports. They currently have a $57.00 price objective on the stock. Benchmark’s price target would suggest a potential upside of 193.97% from the company’s previous close. Separately, HC Wainwright […]
Belite Bio (NASDAQ:BLTE – Get Free Report) and GeoVax Labs (NASDAQ:GOVX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Volatility & Risk Belite Bio has a […]